Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Melexis N.V. Share Issue/Capital Change 2021

Mar 3, 2021

3975_iss_2021-03-03_d2e7524f-6b7b-4f03-bf71-91f798a625c6.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

NOT FOR DISTRIBUTION, RELEASE, OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH-AFRICA OR SWITZERLAND OR ANY PERSON BASED IN THESE COUNTRIES

Xtrion and Melexis have successfully completed private placement of Melexis shares

MAR 3, 2021

Press Release – Inside Information – Regulated Information

Intermediate declaration by the Board of Directors

Ieper, Belgium – March 3rd, 2021, 8.00 hrs CET

Melexis NV ("Melexis"), a global microelectronics engineering company, Melexis Technologies NV ("Melexis Technologies") and Xtrion NV ("Xtrion"), a holding company and majority shareholder of Melexis (jointly referred to as the "sellers"), have successfully completed the private placement of 1,790,539 existing shares - c. 4.43 % of the capital - of Melexis (the "shares").

Following the sale, Xtrion will remain Melexis' majority shareholder (50% + 1 share). It is Xtrion's intention and vision to retain a controlling stake in Melexis' share capital for the foreseeable future.

The shares have been placed at a price of 88.50 EUR per share.

Settlement will take place on March 5th, 2021.

Trading of the Melexis share on Euronext Brussels has been suspended since March 2nd, 2021, 13.30 hrs CET and will resume at market opening today.

Belfius SA/NV, in cooperation with Kepler Cheuvreux S.A., and BNP Paribas Fortis SA/NV acted as Joint Global Coordinators and Joint Bookrunners in connection with the placement.

Important Legal Information

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.